|Articles|February 11, 2008

Latebreakers: Antifungal approved for new indication

Mycamine from Astellas Pharma was given a supplemental indication approval

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.


Latest CME